Granules India informs about press release

22 Oct 2020 Evaluate

Granules India has informed that it has enclosed the press release on 22 October 2020 titled ‘Granules India receives approval for Generic “K-Dur,” equivalent to Klor Con M, potassium chloride tablets for the treatment of Hypokalemia’. This is for the information and dissemination to the members of the exchange.

The above information is a part of company’s filings submitted to BSE.

Granules India Share Price

588.00 5.70 (0.98%)
20-Mar-2026 12:07 View Price Chart
Peers
Company Name CMP
Sun Pharma Inds. 1770.00
Dr. Reddys Lab 1295.90
Cipla 1258.90
Zydus Lifesciences 889.40
Lupin 2309.00
View more..
Register Now to get our Free Newsletter & much more!

© 2026 The Alchemists Ark Pvt. Ltd. All rights reserved. MoneyWorks4Me ® is a registered trademark of The Alchemists Ark Pvt. Ltd.

×